Figure 2
Figure 2. Expression of NKp44 ligands on HIV-infected primary T cells. (A,C) uninfected and (B,D) HIV-1SF162– or HIV-1SF128A–infected CD4+ T cells stained with soluble NKp44/IgG Fc fusion protein and goat antihuman secondary reagent followed by intracellular staining with mouse anti-HIV-1 p24 antibodies. Dot plots shown are of 3 × 104 cells in the viable gate from cultures of T-cell blasts infected with HIV, and the numbers represent the percentage of viable cells within each quadrant. (E) The percentage of HIV-1 p24 Ag+ (–) and p24 Ag− (———) infected cells that are NKp44 ligand-positive. Data are representative of 3 separate studies.

Expression of NKp44 ligands on HIV-infected primary T cells. (A,C) uninfected and (B,D) HIV-1SF162– or HIV-1SF128A–infected CD4+ T cells stained with soluble NKp44/IgG Fc fusion protein and goat antihuman secondary reagent followed by intracellular staining with mouse anti-HIV-1 p24 antibodies. Dot plots shown are of 3 × 104 cells in the viable gate from cultures of T-cell blasts infected with HIV, and the numbers represent the percentage of viable cells within each quadrant. (E) The percentage of HIV-1 p24 Ag+ () and p24 Ag (———) infected cells that are NKp44 ligand-positive. Data are representative of 3 separate studies.

Close Modal

or Create an Account

Close Modal
Close Modal